These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17233530)

  • 1. Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs.
    Thomas BF; Zhang Y; Brackeen M; Page KM; Mascarella SW; Seltzman HH
    AAPS J; 2006 Oct; 8(4):E665-71. PubMed ID: 17233530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.
    Chu CM; Hung MS; Hsieh MT; Kuo CW; Suja TD; Song JS; Chiu HH; Chao YS; Shia KS
    Org Biomol Chem; 2008 Sep; 6(18):3399-407. PubMed ID: 18802648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.
    Lange JH; Kruse CG
    Drug Discov Today; 2005 May; 10(10):693-702. PubMed ID: 15896682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of novel diarylpyrazole imide analogues as CB1 cannabinoid receptor ligands.
    Song KS; Kim MJ; Seo HJ; Lee SH; Jung ME; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2009 Apr; 17(8):3080-92. PubMed ID: 19328001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
    Lange JH; Kruse CG
    Chem Rec; 2008; 8(3):156-68. PubMed ID: 18563799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.
    Krishnamurthy M; Li W; Moore BM
    Bioorg Med Chem; 2004 Jan; 12(2):393-404. PubMed ID: 14723958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-specific homology modeling of human cannabinoid (CB1) receptor.
    Ai R; Chang CE
    J Mol Graph Model; 2012 Sep; 38():155-64. PubMed ID: 23079645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
    Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
    J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the interaction of SR141716A with the CB1 receptor.
    Shim JY; Bertalovitz AC; Kendall DA
    J Biol Chem; 2012 Nov; 287(46):38741-54. PubMed ID: 22995906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: potent, orally-active 1,4-disubstituted imidazoles.
    Dow RL; Hadcock JR; Scott DO; Schneider SR; Paight ES; Iredale PA; Carpino PA; Griffith DA; Hammond M; Dasilva-Jardine P
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5351-4. PubMed ID: 19683918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
    Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
    Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent imidazole and triazole CB1 receptor antagonists related to SR141716.
    Dyck B; Goodfellow VS; Phillips T; Grey J; Haddach M; Rowbottom M; Naeve GS; Brown B; Saunders J
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1151-4. PubMed ID: 14980654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
    Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
    Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.
    Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A
    J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the CB
    Laprairie RB; Vemuri K; Stahl EL; Korde A; Ho JH; Grim TW; Hua T; Wu Y; Stevens RC; Liu ZJ; Makriyannis A; Bohn LM
    Mol Pharmacol; 2019 Nov; 96(5):619-628. PubMed ID: 31515283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
    Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
    Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant.
    Kopka IE; Lin LS; Jewell JP; Lanza TJ; Fong TM; Shen CP; Lao ZJ; Ha S; Castonguay LG; Van der Ploeg L; Goulet MT; Hagmann WK
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4757-61. PubMed ID: 20643546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB
    Asproni B; Murineddu G; Corona P; Pinna GA
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant.
    Menozzi G; Fossa P; Cichero E; Spallarossa A; Ranise A; Mosti L
    Eur J Med Chem; 2008 Dec; 43(12):2627-38. PubMed ID: 18342403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.